Home Table of Contents

§ 15-847.1. Copayment for drug prescribed to treat diabetes, HIV, or AIDS

West's Annotated Code of MarylandInsuranceEffective: January 1, 2023

West's Annotated Code of Maryland
Insurance (Refs & Annos)
Title 15. Health Insurance
Subtitle 8. Required Health Insurance Benefits (Refs & Annos)
Effective: January 1, 2023
MD Code, Insurance, § 15-847.1
§ 15-847.1. Copayment for drug prescribed to treat diabetes, HIV, or AIDS
Currentness
Application of section
(a) This section applies to:
(1) insurers and nonprofit health service plans that provide coverage for prescription drugs under individual, group, or blanket health insurance policies or contracts that are issued or delivered in the State; and
(2) health maintenance organizations that provide coverage for prescription drugs under individual group contracts that are issued or delivered in the State.
In general
(b)(1) Subject to paragraph (2) of this subsection and § 15-822.1 of this subtitle, an entity subject to this section may not impose a copayment or coinsurance requirement on a prescription drug prescribed to treat diabetes, HIV, or AIDS that exceeds $150 for up to a 30-day supply of the drug.
(2) On July 1 each year, the limit on the copayment or coinsurance requirement on a prescription drug prescribed to treat diabetes, HIV, or AIDS shall increase by a percentage equal to the percentage change from the preceding year in the medical care component of the March Consumer Price Index for All Urban Consumers, Washington Metropolitan Area, from the U.S. Department of Labor, Bureau of Labor Statistics.

Credits

Added by Acts 2020, c. 614, § 1, eff. May 8, 2020; Acts 2020, c. 615, § 1, eff. May 8, 2020. Amended by Acts 2022, c. 405, § 1, eff. Jan. 1, 2023.
MD Code, Insurance, § 15-847.1, MD INSURANCE § 15-847.1
Current through legislation effective through July 1, 2024, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document